Moreover, comparable results were obtained in an in vivo imaging study on mice, which was performed with the highly resolving U-SPECT [30]; in this investigation, intraperitoneal application of 2.5 mg/kg amphetamine led to a 27% reduction of [123I]IBZM binding relative to baseline.